The FDA has approved the Accu-Chek Combo system, a combination blood glucose meter and insulin pump that exchanges data using Bluetooth technology.
Manufactured by Roche Diagnostics in Indianapolis, the Accu-Chek system uses a full-color display for blood glucose data, insulin dose information and pump settings, allowing users to remotely calculate and administer a bolus accordingly. Bluetooth technology allows for wireless communication between the insulin pump and user data.
“This new system is designed to support insulin pump patients in managing diabetes easily and discreetly in their everyday life,” said Luc Vierstraete, head of Roche Diabetes Care.
Continue Reading
The device has been launched in several countries in Europe and the Asian-Pacific, according to a press release issued by the company.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.